# Real‐World Efficacy and Safety of Cuticapil Stem Hair Serum as an Add‐On to Minoxidil in Androgenetic Alopecia: A Prospective Observational Study

**Authors:** Rachita Dhurat, Girish R. Kulkarni, Anil Ganjoo, Manjul Agarwal, Pradeep Kumari, Pradyuman Vaidya, Sumit Gupta, Shankar Savant, Rathish Nair, Mahima Agarwal, Pankhuri Agarwal

PMC · DOI: 10.1111/jocd.70247 · Journal of Cosmetic Dermatology · 2025-05-19

## TL;DR

This study shows that adding Cuticapil Stem Hair Serum to standard treatment improves hair growth and reduces hair loss in people with androgenetic alopecia.

## Contribution

The study demonstrates the real-world efficacy and safety of Cuticapil as an add-on treatment for androgenetic alopecia.

## Key findings

- Cuticapil + standard care significantly reduced hair shedding compared to standard care alone.
- The treatment improved hair density and appearance, as shown by photographic analysis.
- No adverse events were reported, confirming the safety of Cuticapil.

## Abstract

Androgenetic alopecia (AGA) is a common age‐related hair loss condition influenced by genetics and androgen activity.

This study evaluated the safety and efficacy of Cuticapil Stem Hair Serum in improving hair loss in AGA patients.

This multicenter, prospective, observational study assessed the real‐world efficacy and safety of Cuticapil Stem Hair Serum in patients with androgenetic alopecia. A total of 60 subjects were evaluated, with the Cuticapil and Standard of Care groups compared using the Mann–Whitney and Wilcoxon signed‐rank tests. Key assessments included the hair pull test, global photographic analysis, and hair shedding count. No adverse events were reported, reinforcing the serum's favorable safety profile.

The Cuticapil + SoC treatment group consistently showed higher mean ranks across multiple parameters compared to the SoC‐only group. The addition of Cuticapil Serum to SoC significantly reduced hair shedding (p = 0.0220). In the Hair Pull Test, the Cuticapil + SoC group had a lower mean rank (26.97) than SoC alone (34.03) (p = 0.0196), indicating greater efficacy. Global photography analysis showed a higher mean rank of 36.13 in the Cuticapil + SoC group compared to 24.87 in the SoC group (p = 0.0057), further supporting its effectiveness.

Cuticapil Stem Hair Serum, when used in addition to standard care, significantly enhances hair growth and reduces hair fall in patients with mild to moderate Androgenetic Alopecia and Female Pattern Hair Loss. It showed superior results in promoting hair growth, reducing shedding, improving hair density, appearance, and managing hair loss.

## Linked entities

- **Diseases:** Androgenetic Alopecia (MONDO:0005339)

## Full-text entities

- **Diseases:** AGA (MESH:D000505)
- **Chemicals:** Cuticapil (-), SoC (MESH:C001599), Minoxidil (MESH:D008914)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12086745/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12086745/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12086745/full.md

---
Source: https://tomesphere.com/paper/PMC12086745